693.28美元6(0.87%)
2025/03/14更新
績效 / 1月1.93%
3月0.79%
1年5.45%
晨星評等 - 1.現金0.00%
- 2.股票27.50%
- 3.債券0.00%
- 4.其他72.50%
- 1.美國72.50%
- 2.歐洲不包含歐元區14.55%
- 3.日本6.83%
- 4.英國2.73%
- 5.大洋洲1.30%
- 1.Eli Lilly and Co10.32%
- 2.UnitedHealth Group Inc7.34%
- 3.Roche Holding AG6.50%
- 4.Johnson & Johnson6.29%
- 5.Gilead Sciences Inc5.94%
- 6.Novo Nordisk AS Class B4.90%
- 7.Intuitive Surgical Inc4.66%
- 8.Cencora Inc3.94%
- 9.Merck & Co Inc3.92%
- 10.Vertex Pharmaceuticals Inc3.88%
- 1.現金0.00%
- 2.股票27.50%
- 3.債券0.00%
- 4.其他72.50%
- 1.美國72.50%
- 2.歐洲不包含歐元區14.55%
- 3.日本6.83%
- 4.英國2.73%
- 5.大洋洲1.30%
- 1.Eli Lilly and Co10.32%
- 2.UnitedHealth Group Inc7.34%
- 3.Roche Holding AG6.50%
- 4.Johnson & Johnson6.29%
- 5.Gilead Sciences Inc5.94%
- 6.Novo Nordisk AS Class B4.90%
- 7.Intuitive Surgical Inc4.66%
- 8.Cencora Inc3.94%
- 9.Merck & Co Inc3.92%
- 10.Vertex Pharmaceuticals Inc3.88%